A Study of the Pharmacokinetics and Safety of Varespladib in Subjects With Normal or Impaired Renal Function
Status:
Terminated
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare and evaluate the pharmacokinetic characteristics and
the safety of varespladib methyl in mild or moderate renal impairment patients and healthy
volunteers.